DOI: 10.47582/jompac.1954749 ISSN: 2717-7505
Viral etiology, organ support requirements, and 28-day mortality in critically ill patients with PCR-confirmed respiratory viral pneumonia
Erdem Yalçınkaya, Umut Sabri Kasapoğlu, Hüseyin Arıkan, Fatma Betül Yıldırım, Sait Karakurt Aims: Respiratory viral pneumonia is an important cause of acute respiratory failure requiring intensive care unit admission. However, the clinical course of critically ill patients may be influenced not only by viral etiology but also by acute illness severity, organ support requirements, and microbiological co-detection. This study aimed to evaluate viral etiology, organ support requirements, microbiological findings, laboratory and radiologic characteristics, and 28-day mortality in critically ill patients with PCR-confirmed respiratory viral pneumonia. Methods: This single-center, record-based observational cohort study with retrospective data extraction included adult patients admitted directly from the emergency department to a tertiary-care medical ICU with acute respiratory failure, radiographic pneumonic infiltration, and PCR-confirmed respiratory viral pneumonia. Respiratory viral PCR samples were obtained during ICU admission using nasopharyngeal swabs. The primary outcome was 28-day all-cause mortality after ICU admission. Results: Seventy-nine patients were included. The median age was 72 years, and 46 patients were male. Twenty-eight-day mortality occurred in 26 patients (32.9%). Viral etiology was heterogeneous; influenza A was the most frequent pathogen, followed by rhinovirus/enterovirus and SARS-CoV-2. No statistically significant difference was observed between survivors and non-survivors according to individual viral categories; however, viral subgroup sizes were small. Non-survivors more frequently required invasive mechanical ventilation, vasopressor support, and continuous renal replacement therapy. Respiratory-source bacterial/fungal co-detection or infection was also more frequent among non-survivors. Baseline inflammatory biomarkers and parenchymal CT patterns did not differ significantly between survivors and non-survivors. Conclusion: In this small retrospective ICU cohort of patients with PCR-confirmed respiratory viral pneumonia, 28-day mortality was substantial. Non-survivors had higher rates of organ support requirements and respiratory-source bacterial/fungal co-detection or infection, while no significant mortality difference was observed across individual viral categories. These findings should be interpreted cautiously because of the retrospective design, small viral subgroups, and potential time dependent and confounding biases.
More from our Archive
-
DOI: 10.1145/3845995 2026
A Survey of LLM-based Software Repair: Taxonomies, Design Paradigms, and Applications Boyang Yang, Zijian Cai, Fengling Liu, Bach Le, Lingming Zhang, Tegawendé F. Bissyandé, Yang Liu, Haoye Tian
-
DOI: 10.1108/jrim-02-2024-0074 2026
Cutting-edge research in social media and interactive marketing: a
review and research agenda James W Peltier, Andrew J Dahl, Lauren Drury, Tracy Khan
-
DOI: 10.1108/jkm-04-2021-0336 2026
Knowledge hiding – a systematic review and research
agenda Amitabh Anand, Florian Offergelt, Payal Anand
-
DOI: 10.1257/aer.20230448 2026
The Unequal Economic Consequences of Carbon Pricing Diego R. Känzig
-
DOI: 10.1017/awf.2026.10115 2026
Part 1: Assessment of upright restraint of broilers for head-only electrical stunning Troy J. Gibson, Georgina Limon, Shannon Campbell, Natalie Chancellor, Katharine A Fletcher, Paul Berry, Jeff Lines
-
DOI: 10.21468/scipostphyscodeb.86 2026
MadAgents Tilman Plehn, Daniel Schiller, Nikita Schmal
-
DOI: 10.21468/scipostphyscodeb.86-r2.0 2026
Codebase release 2.0 for MadAgents Tilman Plehn, Daniel Schiller, Nikita Schmal
-
DOI: 10.21468/scipostphyscodeb.85 2026
svPITE: A Python package for the state-vector-based probabilistic imaginary-time evolution algorithm Pascal Sievers, Satoshi Ejima
-
DOI: 10.21468/scipostphyscodeb.85-r1.1 2026
Codebase release 1.1 for svPITE Pascal Sievers, Satoshi Ejima
-
DOI: 10.1177/02611929261494117 2026
The World Medical Association’s
Declaration of Helsinki
and
Statement on Animal Use in Biomedical Research
: Why reliable and valid preclinical evidence and Natalie Anderson, Jane Kotzmann, Rachel Smith, Kathrin Herrmann